Literature DB >> 27677100

Steroid vs. Platelet-Rich Plasma in Ultrasound-Guided Sacroiliac Joint Injection for Chronic Low Back Pain.

Varun Singla1, Yatindra K Batra2, Neerja Bharti3, Vijay G Goni4, Neelam Marwaha5.   

Abstract

BACKGROUND: Despite widespread use of steroids to treat sacroiliac joint (SIJ) pain, their duration of pain reduction is short. Platelet-rich plasma (PRP) can potentially enhance tissue healing and may have a longer-lasting effect on pain.
OBJECTIVES: To assess the efficacy and safety of PRP compared with methylprednisolone in ultrasound-guided SIJ injection for low back pain. STUDY
DESIGN: Prospective randomized open blinded end point (PROBE) study.
METHODS: Forty patients with chronic low back pain diagnosed with SIJ pathology were randomly allocated into 2 groups. Group S received 1.5 mL of methylprednisolone (40 mg/mL) and 1.5 mL of 2% lidocaine with 0.5 mL of saline, while Group P received 3 mL of leukocyte-free PRP with 0.5 mL of calcium chloride into ultrasound-guided SIJ injection. Visual analog scale (VAS) scores, Modified Oswestry Disability Questionnaire (MODQ) scores, Short Form (SF-12) Health Survey scores, and complications (if any) were evaluated at 2 weeks, 4 weeks, 6 weeks, and 3 months.
RESULTS: Intensity of pain was significantly lower in Group P at 6 weeks (median [interquartile range (IQR)] = 1 [1 to 1] vs. 3.5 [2 to 5]; P = 0.0004) and 3 months (Median [IQR] = 1 [1 to 3] vs. 5 [3 to 5]; P = 0.0002) as compared to Group S. The efficacy of steroid injection was reduced to only 25% at 3 months in Group S, while it was 90% in Group P. A strong association was observed in patients receiving PRP and showing a reduction of VAS ≥ 50% from baseline when other factors were controlled. The MODQ and SF-12 scores were improved initially for up to 4 weeks but deteriorated further at 3 months in Group S, while both the scores improved gradually for up to 3 months in Group P.
CONCLUSION: The intra-articular PRP injection is an effective treatment modality in low back pain involving SIJ.
© 2016 World Institute of Pain.

Entities:  

Keywords:  low back pain; methylprednisolone; platelet-rich plasma; prospective randomized open blinded end point study; sacroiliac joint injection; ultrasound-guided

Mesh:

Substances:

Year:  2016        PMID: 27677100     DOI: 10.1111/papr.12526

Source DB:  PubMed          Journal:  Pain Pract        ISSN: 1530-7085            Impact factor:   3.183


  4 in total

Review 1.  Minimally Invasive and Conservative Interventions for the Treatment of Sacroiliac Joint Pain: A Review of Recent Literature.

Authors:  Mayank Aranke; Grace McCrudy; Kelsey Rooney; Kunaal Patel; Christopher A Lee; Jamal Hasoon; Alan D Kaye
Journal:  Orthop Rev (Pavia)       Date:  2022-05-31

Review 2.  Do Corticosteroids Still Have a Place in the Treatment of Chronic Pain?

Authors:  Nebojsa Nick Knezevic; Filip Jovanovic; Dimitry Voronov; Kenneth D Candido
Journal:  Front Pharmacol       Date:  2018-11-01       Impact factor: 5.810

Review 3.  Diagnosis and interventional pain management options for sacroiliac joint pain.

Authors:  Ching-Wei Chuang; Sheng-Kai Hung; Po-Ting Pan; Ming-Chang Kao
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2019-09-16

Review 4.  Lumbar instability as an etiology of low back pain and its treatment by prolotherapy: A review.

Authors:  Ross A Hauser; Danielle Matias; David Woznica; Benjamin Rawlings; Barbara A Woldin
Journal:  J Back Musculoskelet Rehabil       Date:  2022       Impact factor: 1.456

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.